Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia
Adequate dialysis defined by a KT/V index ≥ 1.4
No active inflammatory process or infection
Age ≥ 18 years
Receiving standard hemodialysis regimen three times weekly, at least 4 hours per session
Current use of steroids or immunosuppressive therapy
History of kidney transplantation
Diagnosis of cancer
Pregnancy
Parallel
Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafron HA130 contains the original adsorbing material.
DeviceThe test cartridge will be used in addition to the ongoing program hemodialysis three times a week in the first month, twice a week in the next month, once a week in the third month
Change from baseline in serum IL-6, pg/ml
Change frome baseline in serum IL-1, pg/ml
Change from baseline in serum IL-8, pg/ml
Change from baseline in serum IL-10, pg/ml
Change from baseline in CRP, mg/L
Click on the lead sponsor to view all of their trials.
